skip to Main Content

Share the Science with Dr. Omar Aljitawi Promising Strategies to Improve Umbilical Cord Blood Transplant Outcomes

Mediware and Save the Cord Foundation are proud to bring you this exclusive speaker series. Join us and your colleagues as they share their latest research, opinions on industry news, and so much more. We look forward to having you…


Recorded Webinar Goodbye Paper, Hello Transtem: Cellular Laboratory Operations, Compliance and Regulatory Management System

Wednesday, June 14 | 2017 Listen to Jonathan Wofford, General Manager and Jenny Sander, business analyst for Mediware’s cellular therapy division, discuss how Transtem Lab drives operational efficiency and increased compliance. While enhanced analytics allow you to easily compile utilization…


Upcoming Share the Science Webinar with Dr. Timothy Nelson: Strengthening the HLHS Heart Using Umbilical Cord Blood

Mediware and Save the Cord Foundation are proud to bring you this exclusive speaker series to discuss the topics you and your peers are most interested in. Join us as we feature your colleagues to discuss their latest research, opinions on…


“Finding a Matched Donor in the Global Village” – Immuno-genetic Challenges of Tissue Typing

Mediware and Save the Cord Foundation are proud to bring you this exclusive speaker series. Join us and your colleagues as they share their latest research, opinions on industry news, and so much more. We look forward to having you…


“Immune Reconstitution after Stem Cell Transplant” – Challenges and Opportunities

Recorded: Thursday, February 23rd Share the Science Series Watch this webinar to hear Dr. Miguel-Angel Perales, M.D., discuss the factors influencing immune recovery post allogeneic HCT, the clinical consequences of delayed immune recovery post allogeneic HCT, and the potential strategies…


Share the Science Webinar with Dr. Moshe Israeli: Finding a Matched Donor in the Global Village

Tuesday, March 14, 2017 Share the Science Register for this webinar to hear Dr. Moshe Israeli, director of the tissue typing laboratory at Rabin Medical Center in Israel, discuss the fascinating clinical world of immunogenetics. During this hour-long event, Dr.…


Recorded Webinar with Dr. Charles S. Cox Jr.: Cellular Therapies for Neurological Injury

Register for the webinar to hear Dr. Charles S. Cox Jr., who is a professor of pediatric surgery and the George and Cynthia Mitchell Distinguished Chair in Neuroscience as well as the director of the Pediatric Surgical Translational Laboratories and Pediatric Program in Regenerative Medicine at the University of Texas Medical School at Houston, discuss various stem and progenitor cellular therapies as potential treatments for neurological injuries, the differences between these many cell types, preclinical and early clinical trials occurring in the field, and future outlooks.


Recorded Webinar with Dr. Colleen Delaney: Clinical Applications of Expanded Cord Blood Progenitor Cells

Watch the recorded webinar to hear Dr. Colleen Delaney, chief medical officer and scientific founder at Nohla Therapeutics, discuss development and methodologies for the ex vivo expansion of cord blood stem and progenitor cells, and the clinical application of these cells for cord blood transplant and chemotherapy-induced neutropenia.


Recorded Webinar with Linda Peltier: How to Potentialize Donations to Cord Blood Banks

Watch the recorded webinar to hear Linda Peltier, research associate at McGill University, discuss how new compliance regulations impact public cord blood banks, why the current operational model must be modified, and ways to recover cord blood and tissue components for a better operational cost.


Recorded Webinar with Morey Kraus: Perinatal Stem Cells from Umbilical Cord Tissue and Their Potential Use in Newborns with Hypoxic Ischemic Injuries

Watch the recorded webinar to hear Morey Kraus, chief scientific officer at PerkinElmer Diagnostics and ViaCord, discuss perinatal stem cells, potential applications of these stem cells in regenerative medicine, and their potential use in newborns with hypoxic ischemic injuries.